← Back
$STOK All transactions

Stoke Therapeutics, Inc.

A

$ Value

$0

Shares

193,000

Price

$0

Filed

Feb 19

Insider

Name

SMITH IAN F

Title

Chief Executive Officer

CIK

0001197032

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-17

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

193,000

Footnotes

The option shall vest as to 1/48 of the total award on March 15, 2026, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon settlement. | The RSU award shall vest as to 1/4 of the total award annually with the first tranche vesting on February 15, 2027, subject to the reporting person's continued service to the issuer through each vesting date.

Filing Info

Accession No.

0001197032-26-000002

Form Type

4

Issuer CIK

0001623526

SMITH IAN F's History

Date Ticker Type Value
2026-04-02 SLDB M
2026-04-02 SLDB M $0
2026-02-17 STOK A $0
2026-02-17 STOK A $0
2026-01-06 SLDB M
2026-01-06 SLDB M $0
2026-01-02 SLDB A $0
2026-01-02 SLDB A $0
2025-10-08 STOK A $0
2025-10-08 STOK A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
SMITH IAN F
Chief Executive Officer
2026-02-17
Hoitt Jason
Chief Patient Officer
2026-02-17
Leggett Thomas
Chief Financial Officer
2026-02-17
Krainer Adrian R. $287K 2026-03-02
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20